Literature DB >> 7532213

Phosphorylation of tau protein by casein kinase-1 converts it to an abnormal Alzheimer-like state.

T J Singh1, I Grundke-Iqbal, K Iqbal.   

Abstract

The microtubule-associated protein tau is abnormally hyperphosphorylated in Alzheimer's disease. Both proline-dependent protein kinases (PDPKs) and non-PDPKs are involved in this hyperphosphorylation of tau. Several PDPKs can phosphorylate tau in vitro and induce Alzheimer-like epitopes to many phosphorylation-dependent antibodies. A similar induction has not been reported with non-PDPKs. In this study we have evaluated six non-PDPKs [cyclic AMP-dependent (A-kinase), calcium/phospholipid-dependent (C-kinase), casein kinase-1 (CK-1), casein kinase-2 (CK-2), calcium/calmodulin-dependent protein kinase II, and calcium/calmodulin-dependent protein kinase from rat cerebellum] for their abilities to induce Alzheimer-like epitopes on tau. Such epitopes were induced by A-kinase, C-kinase, CK-1, and CK-2, but the degree of induction achieved by CK-1 was much greater than with the other kinases. These results suggest that CK-1 may play an important role in the conversion of tau from the normal to the abnormal phosphorylation state in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7532213     DOI: 10.1046/j.1471-4159.1995.64031420.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  19 in total

1.  Non-proline-dependent protein kinases phosphorylate several sites found in tau from Alzheimer disease brain.

Authors:  T J Singh; T Zaidi; I Grundke-Iqbal; K Iqbal
Journal:  Mol Cell Biochem       Date:  1996-01-26       Impact factor: 3.396

Review 2.  Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration.

Authors:  M L Billingsley; R L Kincaid
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

Review 3.  Alzheimer disease therapeutics: focus on the disease and not just plaques and tangles.

Authors:  Khalid Iqbal; Fei Liu; Cheng-Xin Gong
Journal:  Biochem Pharmacol       Date:  2014-01-10       Impact factor: 5.858

4.  Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration.

Authors:  Jian-Zhi Wang; Inge Grundke-Iqbal; Khalid Iqbal
Journal:  Eur J Neurosci       Date:  2007-01       Impact factor: 3.386

5.  Potentiation of GSK-3-catalyzed Alzheimer-like phosphorylation of human tau by cdk5.

Authors:  A Sengupta; Q Wu; I Grundke-Iqbal; K Iqbal; T J Singh
Journal:  Mol Cell Biochem       Date:  1997-02       Impact factor: 3.396

6.  Protein kinase C and calcium/calmodulin-dependent protein kinase II phosphorylate three-repeat and four-repeat tau isoforms at different rates.

Authors:  T J Singh; I Grundke-Iqbal; W Q Wu; V Chauhan; M Novak; E Kontzekova; K Iqbal
Journal:  Mol Cell Biochem       Date:  1997-03       Impact factor: 3.396

7.  A new molecular link between the fibrillar and granulovacuolar lesions of Alzheimer's disease.

Authors:  N Ghoshal; J F Smiley; A J DeMaggio; M F Hoekstra; E J Cochran; L I Binder; J Kuret
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

Review 8.  Mechanisms of tau-induced neurodegeneration.

Authors:  Khalid Iqbal; Fei Liu; Cheng-Xin Gong; Alejandra Del C Alonso; Inge Grundke-Iqbal
Journal:  Acta Neuropathol       Date:  2009-01-30       Impact factor: 17.088

9.  Regulation of Alzheimer's disease amyloid-beta formation by casein kinase I.

Authors:  Marc Flajolet; Gen He; Myriam Heiman; Angie Lin; Angus C Nairn; Paul Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-27       Impact factor: 11.205

Review 10.  Developing pharmacological therapies for Alzheimer disease.

Authors:  K Iqbal; I Grundke-Iqbal
Journal:  Cell Mol Life Sci       Date:  2007-09       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.